Increased levels of soluble C5b-9 (sC5b-9) have been detected in patients with acute TTP, probably due to the activation of the classical complement pathway by immunocomplexes of ADAMTS-13 and anti-ADAMTS-13 antibodies (146). The gene discussed is ADAMTS13; the disease is thrombotic thrombocytopenic purpura.